137 related articles for article (PubMed ID: 25678707)
1. Dynamic regulation of platelet-derived growth factor D (PDGF-D) activity and extracellular spatial distribution by matriptase-mediated proteolysis.
Huang W; Kim HR
J Biol Chem; 2015 Apr; 290(14):9162-70. PubMed ID: 25678707
[TBL] [Abstract][Full Text] [Related]
2. A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.
Ustach CV; Huang W; Conley-LaComb MK; Lin CY; Che M; Abrams J; Kim HR
Cancer Res; 2010 Dec; 70(23):9631-40. PubMed ID: 21098708
[TBL] [Abstract][Full Text] [Related]
3. Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.
Najy AJ; Dyson G; Jena BP; Lin CY; Kim HR
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C293-304. PubMed ID: 26157007
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.
Hurst NJ; Najy AJ; Ustach CV; Movilla L; Kim HR
Biochem J; 2012 Feb; 441(3):909-18. PubMed ID: 22035541
[TBL] [Abstract][Full Text] [Related]
5. Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.
Najy AJ; Won JJ; Movilla LS; Kim HR
Mol Cancer Res; 2012 Aug; 10(8):1087-97. PubMed ID: 22689130
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.
Fredriksson L; Ehnman M; Fieber C; Eriksson U
J Biol Chem; 2005 Jul; 280(29):26856-62. PubMed ID: 15911618
[TBL] [Abstract][Full Text] [Related]
7. Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity.
Tseng CC; Jia B; Barndt R; Gu Y; Chen CY; Tseng IC; Su SF; Wang JK; Johnson MD; Lin CY
PLoS One; 2017; 12(8):e0183507. PubMed ID: 28829816
[TBL] [Abstract][Full Text] [Related]
8. The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to β-amyloid peptide.
Lanchec E; Désilets A; Béliveau F; Flamier A; Mahmoud S; Bernier G; Gris D; Leduc R; Lavoie C
J Biol Chem; 2017 Dec; 292(50):20669-20682. PubMed ID: 29054928
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic cleavage of Trop2 at Arg87 is mediated by matriptase and regulated by Val194.
Kamble PR; Rane S; Breed AA; Joseph S; Mahale SD; Pathak BR
FEBS Lett; 2020 Oct; 594(19):3156-3169. PubMed ID: 32761920
[TBL] [Abstract][Full Text] [Related]
10. Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling.
Le Gall SM; Szabo R; Lee M; Kirchhofer D; Craik CS; Bugge TH; Camerer E
Blood; 2016 Jun; 127(25):3260-9. PubMed ID: 27114461
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
Stirnberg M; Maurer E; Horstmeyer A; Kolp S; Frank S; Bald T; Arenz K; Janzer A; Prager K; Wunderlich P; Walter J; Gütschow M
Biochem J; 2010 Aug; 430(1):87-95. PubMed ID: 20518742
[TBL] [Abstract][Full Text] [Related]
12. Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor.
Chen M; Chen LM; Lin CY; Chai KX
Mol Cell Biochem; 2010 Apr; 337(1-2):259-66. PubMed ID: 19911255
[TBL] [Abstract][Full Text] [Related]
13. A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression.
Ustach CV; Taube ME; Hurst NJ; Bhagat S; Bonfil RD; Cher ML; Schuger L; Kim HR
Cancer Res; 2004 Mar; 64(5):1722-9. PubMed ID: 14996732
[TBL] [Abstract][Full Text] [Related]
14. Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.
Szabo R; Netzel-Arnett S; Hobson JP; Antalis TM; Bugge TH
Biochem J; 2005 Aug; 390(Pt 1):231-42. PubMed ID: 15853774
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer.
Komatsubara T; Oshiro H; Sakuma Y; Sata N; Niki T; Fukushima N
Pathol Int; 2019 Feb; 69(2):86-93. PubMed ID: 30729623
[TBL] [Abstract][Full Text] [Related]
16. PDGF-D Prodomain Differentially Inhibits the Biological Activities of PDGF-D and PDGF-B.
Li L; Wu D; Qin X; Mi LZ
J Mol Biol; 2022 Aug; 434(16):167709. PubMed ID: 35777468
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor (PDGF)-C, a PDGF family member with a vascular endothelial growth factor-like structure.
Reigstad LJ; Sande HM; Fluge Ø; Bruland O; Muga A; Varhaug JE; Martinez A; Lillehaug JR
J Biol Chem; 2003 May; 278(19):17114-20. PubMed ID: 12598536
[TBL] [Abstract][Full Text] [Related]
18. HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase.
Nonboe AW; Krigslund O; Soendergaard C; Skovbjerg S; Friis S; Andersen MN; Ellis V; Kawaguchi M; Kataoka H; Bugge TH; Vogel LK
Traffic; 2017 Jun; 18(6):378-391. PubMed ID: 28371047
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation.
Shibamiya A; Muhl L; Tannert-Otto S; Preissner KT; Kanse SM
Biochem J; 2007 May; 404(1):45-50. PubMed ID: 17300216
[TBL] [Abstract][Full Text] [Related]
20. Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2.
Chiu YL; Wu YY; Barndt RB; Yeo YH; Lin YW; Sytwo HP; Liu HC; Xu Y; Jia B; Wang JK; Johnson MD; Lin CY
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):692-702. PubMed ID: 30777474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
